Myeloproliferative disease articles within Scientific Reports

Featured

• Article
  24 April 2024 | Open Access

  Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients

  • Jhemerson F. Paes
  • , Dania G. Torres
  •  & Lucivana P. de Souza Mourão

• Article
  06 January 2024 | Open Access

  A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis

  • Johannes Lübke
  • , Nicole Naumann
  •  & Juliana Schwaab

• Article
  20 August 2022 | Open Access

  Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis

  • Julia Riffel
  • , Johannes Lübke
  •  & Philipp Riffel

• Article
  10 January 2022 | Open Access

  Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

  • Marta Solans
  • , Arantza Sanvisens
  •  & Rafael Marcos-Gragera

• Article
  08 September 2021 | Open Access

  Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms

  • Jinyong Kim
  • , Ja Min Byun
  •  & Soo-Mee Bang

• Article
  06 September 2021 | Open Access

  Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia

  • Tadaaki Inano
  • , Marito Araki
  •  & Norio Komatsu

• Article
  09 February 2021 | Open Access

  Automated diagnostic support system with deep learning algorithms for distinction of Philadelphia chromosome-negative myeloproliferative neoplasms using peripheral blood specimen

  • Konobu Kimura
  • , Tomohiko Ai
  •  & Yoko Tabe

• Article
  27 April 2020 | Open Access

  Differential cytokine network profile in polycythemia vera and secondary polycythemia

  • Maira da Costa Cacemiro
  • , Juçara Gastaldi Cominal
  •  & Fabíola Attié de Castro

• Article
  27 December 2019 | Open Access

  CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms

  • Tanja Belcic Mikic
  • , Tadej Pajic
  •  & Matjaz Sever

• Article
  22 July 2019 | Open Access

  Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants

  • Simona Salati
  • , Elena Genovese
  •  & Rossella Manfredini

• Article
  09 July 2019 | Open Access

  Reversine exhibits antineoplastic activity in JAK2^V617F-positive myeloproliferative neoplasms

  • Keli Lima
  • , Jorge Antonio Elias Godoy Carlos
  •  & João Agostinho Machado-Neto

• Article
  07 May 2019 | Open Access

  Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly

  • Matthew Ku
  • , Ruth N. MacKinnon
  •  & Harshal Nandurkar

• Article
  28 July 2017 | Open Access

  Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations

  • Helene Myrtue Nielsen
  • , Christen Lykkegaard Andersen
  •  & Kirsten Grønbæk

• Article
  26 May 2017 | Open Access

  A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm

  • D. A. Casolari
  • , T. Nguyen
  •  & R. J. D’Andrea

• Article
  27 January 2017 | Open Access

  The spleen microenvironment influences disease transformation in a mouse model of KIT^D816V-dependent myeloproliferative neoplasm

  • Natalie Pelusi
  • , Maike Kosanke
  •  & Hubert Schorle

• Article
  13 December 2016 | Open Access

  Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms

  • Cecilia P. Marin Oyarzún
  • , Agostina Carestia
  •  & Paula G. Heller